New management approaches for gastroparesis

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 2, Issue 10, 2005, Pages 454-462

  Rayner, Christopher K ^a   Horowitz, Michael ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Gastric emptying; Gastric motility; Gastroparesis; Prokinetic; Therapy

Indexed keywords

ALEMCINAL; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTINOCICEPTIVE AGENT; BETHANECHOL; BOTULINUM TOXIN; BUSPIRONE; CHOLINESTERASE INHIBITOR; CISAPRIDE; CLONIDINE; DOMPERIDONE; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; FEDOTOZINE; GHRELIN; GRANISETRON; KC 11458; METOCLOPRAMIDE; ONDANSETRON; PLACEBO; PROCHLORPERAZINE; PROKINETIC AGENT; PROMETHAZINE; SEROTONIN 1 AGONIST; SILDENAFIL; SULPIRIDE; SUMATRIPTAN; TEGASEROD; TROPISETRON; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; CORRELATION ANALYSIS; DIARRHEA; DYSTONIA; ECHOGRAPHY; ELECTROSTIMULATION; EXTRAPYRAMIDAL SYMPTOM; GASTRECTOMY; GASTROINTESTINAL SYMPTOM; GASTROSTOMY; HEART ARRHYTHMIA; HUMAN; HYPERPROLACTINEMIA; INFORMATION RETRIEVAL; INTESTINE TRANSIT TIME; JEJUNOSTOMY; LONG TERM CARE; LOW DRUG DOSE; MEDLINE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TRANSPLANTATION; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEDATION; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH PARESIS; STOMACH SCINTISCANNING; SYSTEMATIC REVIEW; TACHYPHYLAXIS; TARDIVE DYSKINESIA; UREA BREATH TEST; VOMITING;

BOTULINUM TOXINS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ELECTRIC STIMULATION THERAPY; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; GASTROPARESIS; HUMANS;

EID: 27744548276     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0283     Document Type: Review

References (72)

1. Jones MP and Maganti K (2003) A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 98: 2122-2129
2. Soykan I et al. (11998) Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 43: 2398-2404
3. Talley NJ (2003) Diabetic gastropathy and prokinetics. Am J Gastroenterol 98: 264-271
4. Tack J and Lee KJ (2005) Pathophysiology and treatment of functional dyspepsia. J Clin Gastroenterol 39 (Suppl): S211-S216
5. Jones KL et al. (2001) Predictors of delayed gastric emptying in diabetes. Diabetes Care 24: 1264-1269
6. Horowitz M et al. (1991) Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. EurJ Nucl Med 18: 229-234
7. Parkman HP et al. (2004) American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127: 1592-1622
8. O'Donovan D et al. (2003) Idiopathic and Diabetic Gastroparesis. Curr Treat Options Gastroenterol 6: 299-309
9. Ritz MA et al. (2000) Impacts and patterns of disturbed gastrointestinal function in critically ill patients. Am J Gastroenterol 95: 3044-3052
10. Horowitz M etal. (1994) Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci 39 (Suppl): 7S-13S
11. Horowitz M et al. (2002) Gastric emptying in diabetes: Clinical significance and treatment. Diabet Med 19: 177-194
12. Mearin F et al. (1986) Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 90: 1919-1925
13. Fraser R. et al. (1993) Organization of antral, pyloric and duodenal motility in patients with gastroparesis. J Gastrointest Mot 5: 167-175
14. Rayner CK et al. (2001) Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 24: 371-381
15. Lee KJ et al. (2004) Pathophysiology of functional dyspepsia. Best Pract Res Clin Gastroenterol 18: 707-716
16. Tack J et al. (1998) Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115: 1346-1352
17. Azpiroz F and Malagelada JR (1987) Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 92: 934-943
18. Malagelada JR et al. (1980) Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: Effect of metoclopramide and bethanechol. Gastroenterology 78: 286-293
19. Camilleri M et al. (1998) Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 115: 747-762
20. Wright RA et al. (1985) Diabetic gastroparesis: An abnormality of gastric emptying of solids. Am J Med Sci 289: 240-242
21. Tougas G et al. (2000) Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting. Am J Gastroenterol 95: 78-86
22. De Schepper HU et al. (2004) Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 16: 275-285
23. Parkman HP et al. (2003) Electrogastrography: A document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force. Neurogastroenterol Motil 15: 89-102
24. Koch KL et al. (1989) Gastric emptying and gastric myoslectrical activity in patients with diabetic gastroparesis: Effect of long-term domperidone treatment. Am J Gastroenterol 84: 1069-1075
25. Horowitz M et al. (2001) Gastroparesis: Prevalence, clinical significance and treatment. Can J Gastroenterol 15: 805-813
26. Jones KL et al. (1999) Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 22: 339-344
27. DiBaise JK et al. (2001) Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers. Am J Gastroenterol 96: 2041-2050
28. Fraser R et al. (1993) Dual effects of cisapride on gastric emptying and antropyloroduodenal motility. Am J Physiol 264: G195-G201
29. Ishii M et al. (1997) Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis. Diabetes Care 20: 1134-1137
30. Tatsuta M et al. (1992) Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 6: 221-228
31. Janssens J et al. (1990) Improvement in gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 322: 1028-1031
32. Arts J et al. (2005) Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 54: 455-460
33. Dhir R and Richter JE (2004) Erythromycin in the short-and long-term control of dyspepsia symptoms in patients with gastroparesis. J Clin Gastroenterol 38: 237-242
34. Edelbroek MA et al. (1993) Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects. J Nucl Med 34: 582-588
35. Talley NJ et al. (2001) Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: A randomised, double blind, placebo controlled trial. Gut 49: 395-401
36. Talley NJ et al. (2000) Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: A randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 14: 1653-1661
37. Russo A et al. (2004) Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. Aliment Pharmacol Ther 20: 333-338
38. Abell TL et al. (1991) Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 36: 616-620
39. Veysey MJ et al. (2001) Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: A prospective, randomised, double blind, placebo controlled trial. Gut 49: 828-834
40. Tonini M et al. (1999) Review article: Cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 13: 1585-1591
41. McHugh S et al. (1992) Cisapride vs metoclopramide. An acute study in diabetic gastroparesis. Dig Dis Sci 37: 997-1001
42. Loo FD et al. (1984) Gastric emptying in patients with diabetes mellitus. Gastroenterology 86: 485-494
43. Ganzini L et al. (1993) The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 163: 1469-1475
44. Shaffer D et al. (2004) Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. J Am Pharm Assoc (Wash DC) 44: 661-665
45. Soykan I et al. (1997) The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 92: 976-980
46. Farup CE et al. (1998) Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care 21: 1699-1706
47. Melga P et al. (1997) Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 20: 55-58
48. Murray CD et al. (2005) Ghrelin enhances gastric emptying in diabetic gastroparesis: A double-blind, placebo-controlled, cross-over study. Gut [doi: 10.1136/gut.2005.069088]
49. Rabine JC and Barnett JL (2001) Management of the patient with gastroparesis. J Clin Gastroenterol 32: 11-18
50. Thumshirn M et al. (1999) Modulation of gastric sensory and motor functions by nitrergic and alpha-2-adrenergic agents in humans. Gastroenterology 116: 573-585
51. Dishy V et al. (2004) The effect of sildenafil on gastric emptying in patients with and-stage renal failure and symptoms of gastroparesis. Clin Pharmacol Ther 76: 281-286
52. Jones KL et al. (2000) Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis. Aliment Pharmacol Ther 14: 937-943
53. Clouse RE (2003) Managing functional bowel disorders from the top down: lessons from a well-designed treatment trial. Gastroenterology 125: 249-253
54. Lacy BE et al. (2002) Botulinum toxin for the treatment of gastroparesis: A preliminary report. Am J Gastroenterol 97: 1548-1552
55. Miller LS et al. (2002) Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 97: 1653-1660
56. McCallum RW et al. (1998) Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 114: 456-461
57. Lin Z et al. (2004) Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care 27: 1071-1076
58. Abell T et al. (2003) Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125: 421-428
59. Abell T et al. (2003) Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. JPEN J Parenter Enteral Nutr 27: 277-281
60. McCallum R et al. (2005) Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis. Clin Gastroenterol Hepatol 3: 49-54
61. Cutts TF et al. (2005) Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil 17: 35-43
62. Ayinala S et al. (2005) Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. Gastrointest Endosc 61: 455-461
63. Mintchev MP et al. (2000) Microprocessor-controlled movement of solid gastric content using sequential neural electrical stimulation. Gastroenterology 118: 258-263
64. Kim CH and Nelson DK (1998) Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis. Gastrointest Endosc 47: 67-70
65. Ejskjaer NT et al. (1999) Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 16: 488-495
66. Watkins PJ et al. (2003) Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med 20: 58-63
67. Yamashita S et al. (2000) Longer-term diabetic patients have a more frequent incidence of nosocomial infections after elective gastrectomy. Anesth Analg 91: 1176-1181
68. Eckhauser FE et al. (1998) Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome. Am Surg 64 711-717
69. Forstner-Barthell AW et al. (1999) Near-total completion gastrectomy for severe postvagotomy gastric stasis: Analysis of early and long-term results in 62 patients. J Gastrointest Surg 3: 15-23
70. Gaber AO et al. (1991) Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants. Dig Dis 9: 437-443
71. Kong MF et al. (1999) Natural history of diabetic gastroparesis. Diabetes Care 22: 503-507
72. Jones KL et al. (2002) A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 113: 449-455